What they were paid
Karyopharm Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $41,413 | $0 | $15,142 | $60,000 | $116,555 |
| FY2024 | $60,000 | $0 | $46,078 | $90,000 | $196,078 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Karyopharm Therapeutics Inc. DEF 14A filed April 13, 2026, accession 0001503802-26-000023, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Karyopharm Therapeutics Inc. filed document, accession 0001503802-26-000023. Every figure is read from that document and cited to the page and table it appears in. Filed April 13, 2026.
Get the Karyopharm Therapeutics Board Governance Report
$116,555 Mansoor Raza Mirza, M.D, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 13, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Karyopharm Therapeutics pays directors a $50,000 cash retainer and $15,142 in Options.
Committees
FY2025 · as the proxy prints themCommercialization and Portfolio
The rest of the Karyopharm Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Barry E. Greene | Lead Independent Director | $130,142 |
| Chen Schor, M.B.A., C.P.A | Independent Director | $85,142 |
| Christy J. Oliger | Independent Director | $95,142 |
| Deepika R. Pakianathan, Ph.D | Independent Director | $105,142 |
| Garen G. Bohlin | Independent Director | $95,142 |
| Richard Paulson, M.B.A | Director | — |
| Zhen Su, M.D., M.B.A | Independent Director | $75,142 |
The full Karyopharm Therapeutics compensation record
free company briefThis page is one director within Karyopharm Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Karyopharm Therapeutics proxy · each links to its own free briefOrder KPTI
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.